On the afternoon of August 27, the "Suzhou Dialogue" series of activities officially kicked off, and six exciting sub-forums were held simultaneously, attracting a lot of attention from both inside and outside the industry. These sub-forums covered multiple topics, including the development of infusion and packaging, the safety selection and application of injection packaging materials, the research and development of pharmaceutical packaging and future trends, the digital transformation and innovative technology in the field of pharmaceutical packaging materials, continuous manufacturing and PAT application practices, and international cutting-edge pharmaceutical packaging solutions. Experts and scholars from home and abroad, industry leaders and representatives of well-known companies were brought together to discuss the latest progress and future trends in the pharmaceutical industry.

Each sub-forum not only showcased the latest research results and technological breakthroughs in the industry, but also provided a valuable communication platform for participants, promoting in-depth interaction and cooperation between industry, academia and research. Let's take a look at the wonderful content of these six sub-forums!

01

"Protecting Health, Leading Innovation-International Cutting-Edge Pharmaceutical Packaging Solutions Exchange Meeting" was successfully held

On August 27, Shuangfeng Gerresheim and Detwyler Pharmaceutical Packaging successfully held the "Protecting Health, Leading Innovation-International Cutting-Edge Pharmaceutical Packaging Solutions Exchange Meeting" during the "Suzhou Dialogue 2024". The main topic of this exchange meeting was clear, with rich levels and in-depth professional discussions. The guest's speech was gripping, the audience was eager to learn, and the scene was crowded.

This exchange meeting was hosted by Mr. Fan Xinhua, General Manager of Changzhou Siyao Pharmaceutical Co., Ltd. Mr. Zhu Bilin, an expert from the Jiangsu Pharmaceutical Packaging and Pharmaceutical Excipients Association, shared with everyone "Exploring the significance of the release of the "Good Manufacturing Practice for Pharmaceutical Packaging Materials" to the high-quality development of the industry". He started from the "Good Manufacturing Practice for Pharmaceutical Packaging Materials" which has caused heated discussions and is called the "National Drug Administration Version of Pharmaceutical Packaging Materials GMP", and explored the significance of the launch of this specification to the high-quality development of the industry.

Mr. Yao Wenzhen, Senior Director of Shuangfeng Gerresheim, gave a special report on "Packaging Innovation and Application of Micro-dose Drug Delivery Systems". Mr. Yao Wenzhen is one of the main drafters of national industry standards such as the "Guidelines for Good Manufacturing Practice for Pharmaceutical Packaging Materials" (GMP), "Technical Guidelines for Change Research on Pharmaceutical Packaging Materials", and "Guidelines for the Evaluation of Appearance Defects of Pharmaceutical Glass Containers". His speech explained the advantages of two types of innovative micro-dose drug delivery packaging, coated bottles and liner bottles, compared with ordinary glass packaging materials from the perspective of process and experimental data.

Mr. Wu Guangming, an expert in pharmaceutical packaging science and technology at Datwyler, gave a wonderful report on "Small nucleic acid drugs, those choices worth 'morality'". Mr. Wu Guangming has a deep understanding of the technology, regulations and selection of pharmaceutical packaging materials. His speech reviewed the development history and current situation of small nucleic acid drugs in China. At the same time, based on the characteristics of the preparation, he studied and discussed some considerations in the selection of packaging materials, and then from the perspective of rubber plug technology, further discussed the impact of packaging material selection on the quality of the preparation.

Ms. Sun Yi, director of the Compatibility Research Technical Committee of the China Pharmaceutical Packaging Association, shared on "Basic Requirements and Key Technical Analysis of Drug and Packaging Compatibility Research". Her speech started from meeting the applicability requirements of drugs, expounded the basic requirements of compatibility research, the systematic relationship between extraction research and leaching research, and took into account the characteristics of packaging materials and drugs, so that the compatibility research results become the safety guards in the life cycle of drugs.

In between the speeches of the four guests, the special session also prepared an exciting lottery session for everyone, and the guests and audience on site participated enthusiastically.

Suzhou Dialogue 2.jpg

02

Lino Special: Focus on injection packaging materials and provide high-quality sustainable application solutions

On the afternoon of August 27, Linuo Special Glass successfully held the Suzhou Dialogue "Injection Packaging Safety Selection and Application Solutions" sub-forum. Focusing on the safety selection and application of injection drug packaging materials, the forum invited industry colleagues and authoritative experts to give speeches or make theme sharing reports. The participating experts conducted in-depth and comprehensive discussions on technological innovation, standard comparison, case analysis, etc. Based on its own strength and industry influence, Linuo Special Glass is committed to providing excellent and sustainable application solutions to meet the dual needs of the market and the environment.Subsequently, Wang Yefei, Vice President of the Pharmacy Department of Hongyun Huaning (Hangzhou) Biopharmaceutical Co., Ltd., shared the considerations and research on the selection of pharmaceutical packaging materials for biological products, from the background of biological products and their particularity, the development needs and considerations of pharmaceutical packaging materials for biological products, and the change management of pharmaceutical packaging materials for biological products. Bao Shuxin, senior consultant of Clarivate Analytics' Life Sciences and Healthcare Division, shared with everyone the research and development and transaction trends of innovative drugs in China. From a global perspective, he analyzed the research and development and transaction trends of innovative drugs in China from multiple aspects, including investment in the pharmaceutical industry, combined innovation results, and industrial survival and development. Innovation is the first driving force for development and the key to achieving high-quality development. Yang Jing, deputy director of Huaqiang Technology Center, shared "Innovative Packaging Technology Empowers the Development of the Injection Industry", including rubber components for pen-type syringes, rubber components for prefilled syringes, and membranes for multi-chamber bag infusions. Many vivid research and development cases. The update and implementation of national standards and regulations for pharmaceutical packaging materials has always been a topic of common concern for pharmaceutical companies and pharmaceutical packaging material manufacturers. Xu Jun, deputy director of the Shanghai Food and Drug Packaging Materials Testing Institute, shared the "Understanding and Application of General Technical Requirements for Rubber Seals for Injection Packaging" in response to the guiding principles for rubber seals for pharmaceutical packaging, which promoted the understanding and application of quality control of rubber seals for syringe packaging by pharmaceutical companies and packaging material companies. Chang Hong, a technical expert in pharmaceutical compatibility research at Microspectra and a co-editor and signatory of the compatibility standards for pharmaceutical process components of the Shanghai Packaging Technology Association, shared the compatibility research strategies and trends for foreign applications. Based on the requirements of regulations such as USP1663/1664 and PQRI and the experience of applying for multiple projects, he summarized the compatibility research strategies for foreign applications and analyzed the content of the upcoming ICH Q3E regulations.

At the same time, Huaqiang Technology brought its core pharmaceutical packaging materials such as pharmaceutical butyl rubber stoppers, multi-layer co-extruded films, and aluminum-plastic combination caps to the three-day "Gusu Dialogue" event.

Suzhou Dialogue 7.jpg

04

Committed to development and innovation, the 2024 "Suzhou Dialogue" Baxter special event was successfully held

On the afternoon of August 27, Baxter (China) Investment Co., Ltd., which plans to spin off the kidney care company Vantive, held a special event titled "Development and Innovation: Pharmaceutical Packaging R&D and Future Trends under Clinical Value Orientation" in the conference hall of Suzhou Dushu Lake World Hotel.

Zhang Wei, President of the China Drug Supervision and Administration Research Association, served as the chairman and delivered a welcome speech to the guests. Yan Jing, Manager of the Regulatory and Registration Affairs Department of Baxter (China) Investment Co., Ltd., hosted the forum.

Silicone tubes are widely used production components in the pharmaceutical industry. They can be used for liquid transmission pipelines, peristaltic pump pipelines, etc. They have good purity and flexibility, thermal stability, and biocompatibility. In the pharmaceutical process, how to evaluate and select silicone tubes is also an important aspect to ensure the controllable quality of drugs. Ma Yunan, former director of the Second Department of Chemical Pharmacy of the Drug Review Center of the State Drug Administration, introduced the "Application Research of Silicone Tubes for Pharmaceutical Production Processes" from the perspectives of the composition, production and quality control, selection and use of silicone tubes.

Wu Chaowu, China Chief Representative of the Active and Intelligent Packaging Industry Association (AIPIA), gave a speech entitled "Development Trends of New Pharmaceutical Packaging" through case analysis and technical introduction, discussing the application of new materials, the development of intelligent packaging technology and the trend of sustainable packaging, and showing the latest achievements and future prospects of new pharmaceutical packaging in ensuring drug quality, safety and environmental protection.

Lu Weiyi, director of the business office of the Shanghai Food and Drug Packaging Materials Testing Institute, gave a speech entitled "Discussion on the Sealing Control of Sterile Large-volume Preparations Throughout the Life Cycle", based on the previous research on the main domestic peritoneal dialysis fluid/washing fluid packaging manufacturers, and conducted a survey and analysis of the more systematic packaging system sealing control information throughout the product life cycle.

Gao Lihui, senior chief engineer of Suzhou (Baxter) Medical Supplies Co., Ltd., introduced the "Regulatory Requirements and Practice Sharing of Simulated Transport Validation". Simulated transportation verification is an important confirmation link to ensure that the quality and safety of drugs are maintained throughout the transportation and storage process. Taking sterile injection preparations as an example, she shared her thoughts and experiences in the transportation verification process of enterprises, and proposed that enterprises should pay attention to the correlation between packaging systems and product types and strengthen the management and control of product transportation links.

Dr. Xie Shitong, associate researcher and master's tutor at the School of Pharmaceutical Science and Technology of Tianjin University, gave a speech entitled "The Development and Innovation of the Pharmaceutical Packaging Industry from an Economic Perspective", which talked about how to look at the development and clinical value of the pharmaceutical packaging industry from an economic perspective, and provided a new perspective for the development of the pharmaceutical packaging industry based on value orientation, and proposed that the innovative value of the pharmaceutical packaging system should be emphasized.

Suzhou Dialogue 8.jpg

05

2024 "Suzhou Dialogue" China Resources Double Crane "Infusion & Packaging Development Forum" was successfully held

On the afternoon of August 27, Double Crane held a special Suzhou Dialogue meeting of the "Infusion & Packaging Development Forum". The meeting focused on the development of infusion products (large-volume injections), and speeches were delivered from packaging forms, production processes, quality control, clinical applications, industry research and other aspects. The forum was chaired by Chen Xianxia, ​​Vice President of China Pharmaceutical Packaging Association and former Deputy Director of the State Economic and Trade Commission, and Zhao Guangyao, General Manager of the Market Development Department of China Resources Double Crane Pharmaceutical Co., Ltd. Yin Zhishuang, Director of China Resources Double Crane Pharmaceutical Co., Ltd., served as the host.

Vice President Chen Xianxia made an opening speech for the conference, affirming that China Resources Double Crane has been making efforts and contributions to promote the technological progress and development of the infusion industry, introduced the meeting process, and said that China Pharmaceutical Packaging Association, as a link and bridge between the government and enterprises, affirmed its role in the development of China's pharmaceutical industry and enterprises.

Liu Wei, Director of the Department of Pharmacy of Beijing You'an Hospital Affiliated to Capital Medical University, gave a keynote report on "Insoluble Particles and Infusion Safety", discussing how to strengthen the management and monitoring of the drug administration process from the aspects of the safety of injection administration, factors affecting the insoluble particles of injections, and safety hazards in clinical infusion treatment, so as to further improve the safety of injection administration.

Cui Zhanjun, an expert in the infusion industry and former deputy general manager of the market development department of a listed pharmaceutical company, shared the "Current Status and Development Trends of the Infusion Industry - New Technologies Guaranteeing Infusion Quality Control", talked about the importance of quality control in infusion, especially the control of insoluble particles and bacterial endotoxins, and comprehensively introduced the application of BFS technology in infusion and the high quality assurance of drugs.

Wang Xiaoling, executive deputy director of the research ward of Beijing Children's Hospital, Capital Medical University, discussed "Improving the Safety of Children's Infusion: Insoluble Particle Control and Drug Compatibility Strategy", and talked about measures to improve the safety of children's infusion from the aspects of the risks of intravenous injection to children, risk control technology, and the establishment of national standards.

At the end of the meeting, President Chen Xianxia awarded all speakers with honorary certificates for speeches and awarded China Resources Double Crane with an honorary certificate for outstanding cooperation units, thanking them for their efforts and support in this forum.

Suzhou Dialogue 9.jpg

06

The Suzhou Dialogue sub-forum hosted by Hong Kong Aoxing Group was a complete success

On the afternoon of August 27, Hong Kong Aoxing Group, an expert in pharmaceutical engineering solutions, held a wonderful exchange event "International Dialogue: Continuous Manufacturing and PAT Application and Practice" at the 2024 Suzhou Dialogue event. The event aims to showcase the company's latest products and technologies, strengthen exchanges and cooperation at home and abroad, and contribute to the development of the pharmaceutical equipment industry. After careful preparation and planning, the event was a complete success.

The event was hosted by Yan Yonghui, General Manager of Industry Sales of Aoxing Group, and Mr. Chen Yuewu, Vice President of the Group, also attended the event. Starting from the development trend of "intelligence" and "digitalization", this forum introduced advanced technologies in the pharmaceutical industry - continuous manufacturing and online testing. The research enthusiasm of both in the entire pharmaceutical industry at home and abroad remains high, and will become the blue ocean market of the pharmaceutical industry in the future.

Yan Yonghui, Chairman of the Sub-forum and General Manager of Hong Kong Aoxing Group, delivered a speech and made a keynote speech on "Discussion on the Construction of OSD Digital Smart Factory Production System". Professor Li Wenlong of Tianjin University of Traditional Chinese Medicine shared a keynote report: From Process Analysis Technology to Continuous Production of Drugs. Mr. Steven Hammond, the head of Pfizer's continuous manufacturing project, gave a report sharing on the theme of "Application and implementation of solid preparation continuous manufacturing". Yang Liu, the scientific liaison officer of the United States Pharmacopeia Convention, gave a keynote report sharing on "Progress towards <1037> Process Analytical Technology Chapter". Mr. David Wandrey, a coating technology expert from Thomas Company in the United States, gave a keynote report sharing on "Continuous tablet coating technology application sharing". Zhang Pengfei, an automation control technology expert from Hong Kong Aoxing Group, shared "Software platform construction and implementation of OSD continuous manufacturing system".

Finally, in the roundtable discussion, Professor Qu Haibin of Zhejiang University, Sebastian Sowinski, a PAT application expert from Sentronic Company of Germany, Yang Jingrui, the formulation manager of AstraZeneca Pharmaceuticals Co., Ltd., and Ji Sai, the deputy general manager and chief engineer of Jiangsu Wangao Pharmaceutical Co., Ltd., had in-depth exchanges on the challenges and opportunities faced by continuous manufacturing in the domestic market.

Through this event, Aoxing Company has further enhanced its position and influence in the industry. More importantly, the event provided a good communication platform for participants and promoted exchanges and cooperation at home and abroad. After the event, Aoxing reached cooperation intentions with a number of companies and pledged to jointly promote the development of the pharmaceutical equipment industry.